Benzoxazine &agr;-1 adrenergic compounds
    1.
    发明授权
    Benzoxazine &agr;-1 adrenergic compounds 失效
    苯并恶嗪α-1肾上腺素能化合物

    公开(公告)号:US06376488B1

    公开(公告)日:2002-04-23

    申请号:US09657296

    申请日:2000-09-07

    IPC分类号: A61K315365

    CPC分类号: C07D519/00

    摘要: The present invention relates to compounds having formula I and to pharmaceutically acceptable salts thereof. Compounds of formula I inhibit &agr;1 adrenoreceptors and may be useful for treating benign prostatic hyperplasia (also called benign prostatic hypertrophy) and other urological diseases such as bladder outlet obstruction, neurogenic bladder and gynecological syndromes.

    摘要翻译: 本发明涉及具有式I的化合物及其药学上可接受的盐。 式I的化合物抑制α1肾上腺素受体,并且可用于治疗良性前列腺增生(也称为良性前列腺肥大)和其它泌尿系统疾病,例如膀胱出口阻塞,神经源性膀胱和妇科综合征。